Effects of probiotics supplement in patients with type 2 diabetes mellitus: A meta-analysis of randomized trials;Efectos del suplemento de probióticos en pacientes con diabetes mellitus tipo 2: metaanálisis de ensayos aleatorizados

Medicina Clinica

Volumn 148, Issue 8, 2017, Pages 362-370

  Hu, Yi meng ^a   Zhou, Feng ^a   Yuan, Yin ^a   Xu, Yan cheng ^a  

^a ZHONGNAN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

Meta analysis; Probiotics; Type 2 diabetes mellitus

Indexed keywords

CHOLESTEROL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; PROBIOTIC AGENT; SYNBIOTIC AGENT; TRIACYLGLYCEROL; BIOLOGICAL MARKER;

CHOLESTEROL BLOOD LEVEL; DATA EXTRACTION; DIABETIC PATIENT; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID METABOLISM; META ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SUPPLEMENTATION; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; METABOLISM; TREATMENT OUTCOME;

BIOMARKERS; BLOOD GLUCOSE; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; HUMANS; LIPID METABOLISM; PROBIOTICS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 85013392709     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2016.11.036     Document Type: Review

References (28)

1. 1 Bunyan, G., World Diabetes Congress 2015: Living with diabetes stream. Diabetes Res Clin Pract [Internet]. 108 (2015), 514–515 Disponible en: http://linkinghub.elsevier.com/retrieve/pii/S0168822715001898.
2. 2 Qin J, Li Y, Cai Z, Li SS, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature [Internet]. 2012;490:55-60. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23023125.
3. 3 WHO expert consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Córdoba, Argentina. October 1, 2001. Disponible en: http://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Health+and+Nutritional+Properties+of+Probiotics+in+Food+including+Powder+Milk+with+Live+Lactic+Acid+Bacteria#2%5Cnhttp://scholar.google.com/scholar?hl=en&btnG=Search&q=intitle:Health+and+Nutrit.
4. 4 Hsieh, F.C., Lee, C.L., Chai, C.Y., Chen, W.T., Lu, Y.C., Wu, C.S., Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond)., 10, 2013, 35.
5. 5 Honda, K., Moto, M., Uchida, N., He, F., Hashizume, N., Anti-diabetic effects of lactic acid bacteria in normal and type 2 diabetic mice. J Clin Biochem Nutr. 51 (2012), 96–101.
6. 6 El Sayed El Khamisy A. Effect of Bifidobacterium and Lactobacillus acidophilus in diabetic rats. The 5 th Arab and 2 nd International Annual Scientific Conference. Mansoura University, Egypt [Internet]. April, 14-15, 2010. p. 1-15. Disponible en: http://diabiotics.com/wp-content/uploads/2014/02/Lactobacillus-Acidophilus-and-Diabetes.pdf.
7. 7 Yadav, H., Jain, S., Sinha, P.R., Oral administration of dahi containing probiotic Lactobacillus acidophilus and Lactobacillus casei delayed the progression of streptozotocin-induced diabetes in rats. J Dairy Res. 75 (2008), 189–195.
8. 8 Razmpoosh E, Javadi M, Ejtahed HS, Mirmiran P. Probiotics as beneficial agents in the management of diabetes mellitus: A systematic review [Internet]. Diabetes Metab Res Rev. 2016;32:143-68. Disponible en: http://doi.wiley.com/10.1002/dmrr.2665.
9. 9 Higgins JP, Altman D. Cochrane Handbook General Methods for Cochrane Reviews: Ch 8: Assessing risk of bias in included studies. En: Cochrane Handbook for Systematic Reviews of Interventions [Internet]. 2011. p. 187-242. Disponible en https://dhosth.files.wordpress.com/2011/12/cochrane-handbook-for-systematic-reviews-of-interventions.pdf.
10. 10 Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions. Version 5.1.0 [actualizado Mar 2011]. En: The Cochrane Collaboration. 2011. Table 7.7.a: Formulae for combining groups.
11. 11 Asemi, Z., Alizadeh, S.A., Ahmad, K., Goli, M., Esmaillzadeh, A., Effects of beta-carotene fortified synbiotic food on metabolic control of patients with type 2 diabetes mellitus: A double-blind randomized cross-over controlled clinical trial. Clin Nutr [Internet]. 25 (2016), 819–825 Disponible en: http://dx.doi.org/10.1016/j.clnu.2015.07.009.
12. 12 Asemi, Z., Khorrami-Rad, A., Alizadeh, S.A., Shakeri, H., Esmaillzadeh, A., Effects of synbiotic food consumption on metabolic status of diabetic patients: A double-blind randomized cross-over controlled clinical trial. Clin Nutr [Internet]. 33 (2014), 198–203 Disponible en: http://dx.doi.org/10.1016/j.clnu.2013.05.015.
13. 13 Asemi, Z., Zare, Z., Shakeri, H., Sabihi, S.S., Esmaillzadeh, A., Effect of multispecies probiotic supplements on metabolic profiles, hs-CRP, and oxidative stress in patients with type 2 diabetes. Ann Nutr Metab. 63 (2013), 1–9.
14. 14 Firouzi, S., Majid, H.A., Ismail, A., Kamaruddin, N.A., Barakatun-Nisak, M.Y., Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: A randomized controlled trial. Eur J Nutr., 2016, 1–16.
15. 15 Mazloom Z, Yousefinejad A, Dabbaghmanesh MH. Effect of probiotics on lipid profile, glycemic control, insulin action, oxidative stress, and inflammatory markers in patients with type 2 diabetes: A clinical trial. Iran J Med Sci [Internet]. 2013; 38:38-43. Disponible en: https://www.ncbi.nlm.nih.gov/pubmed/23645956.
16. 16 Mohamadshahi, M., Veissi, M., Haidari, F., Javid, A.Z., Mohammadi, F., Shirbeigi, E., Effects of probiotic yogurt consumption on lipid profile in type 2 diabetic patients: A randomized controlled clinical trial. J Res Med Sci. 19 (2014), 531–536.
17. 17 Mohamadshahi, M., Veissi, M., Haidari, F., Shahbazian, H., Kaydani, G.A., Mohammadi, F., Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Bioimpacts. 4 (2014), 83–88.
18. 18 Moroti, C., Souza Magri, L., de Rezende Costa, M., Cavallini, D.C., Sivieri, K., Effect of the consumption of a new symbiotic shake on glycemia and cholesterol levels in elderly people with type 2 diabetes mellitus. Lipids Health Dis [Internet]., 11, 2012, 29 Disponible en: http://www.lipidworld.com/content/11/1/29.
19. 19 Shakeri, H., Hadaegh, H., Abedi, F., Tajabadi-Ebrahimi, M., Mazroii, N., Ghandi, Y., et al. Consumption of synbiotic bread decreases triacylglycerol and VLDL levels while increasing HDL levels in serum from patients with type-2 diabetes. Lipids. 49 (2014), 695–701.
20. 20 Tajadadi-Ebrahimi, M., Bahmani, F., Shakeri, H., Hadaegh, H., Hijijafari, M., Abedi, F., et al. Effects of daily consumption of synbiotic bread on insulin metabolism and serum high-sensitivity c-reactive protein among diabetic patients: A double-blind, randomized, controlled clinical trial. Ann Nutr Metab. 65 (2014), 34–41.
21. 21 Tonucci, L.B., Olbrich dos Santos, K.M., Licursi de Oliveira, L., Rocha Ribeiro, S.M., Duarte Martino, H.S., Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clin Nutr [Internet]., En prensa 2015 Disponible en: http://dx.doi.org/10.1016/j.clnu.2015.11.011.
22. 22 Hove, K.D., Brøns, C., Færch, K., Lund, S.S., Rossing, P., Vaag, A., Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: A randomised double-blind placebo-controlled study. Eur J Endocrinol. 172 (2015), 11–20.
23. 23 Patel, T.P., Rawal, K., Bagchi, A.K., Akolkar, G., Bernardes, N., da Silva Dias, D., et al. Insulin resistance: An additional risk factor in the pathogenesis of cardiovascular disease in type 2 diabetes. Heart Fail Rev. 21 (2016), 11–23.
24. 24 Wang, J., Tang, H., Zhang, C., Zhao, Y., Derrien, M., Rocher, E., et al. Modulation of gut microbiota during probiotic-mediated attenuation of metabolic syndrome in high fat diet-fed mice. ISME J [Internet]. 9 (2015), 1–15 Disponible en: http://dx.doi.org/10.1038/ismej.2014.99.
25. 25 Warnakulasuriya, M.A., Brennan, C.S., Flint, S., Ranaweera, K.K., Bamunuarachchi, A., Morton, H.R., Enhancement of short chain fatty acid formation by pure cultures of probiotics on rice fibre. Int J Food Sci Technol. 45 (2010), 690–696.
26. 26 Sadrzadeh-Yeganeh, H., Elmadfa, I., Djazayery, A., Jalali, M., Heshmat, R., Chamary, M., The effects of probiotic and conventional yoghurt on lipid profile in women. Br J Nutr [Internet]. 103 (2010), 1778–1783 Disponible en: http://journals.cambridge.org/action/displayFulltext?type=6&fid=7807666&jid=BJN&volumeId=103&issueId=12&aid=7807665&bodyId=&membershipNumber=&societyETOCSession=&fulltextType=RA&fileId=S0007114509993801.
27. 27 Di Gioia, M., Zanoni, I., Toll-like receptor co-receptors as master regulators of the immune response. Mol Immunol. 63 (2015), 143–152.
28. 28 Ovadia, H., Haim, Y., Nov, O., Almog, O., Kovsan, J., Bashan, N., et al. Increased adipocyte S-nitrosylation targets anti-lipolytic action of insulin: Relevance to adipose tissue dysfunction in obesity. J Biol Chem. 286 (2011), 30433–30443.